BioAlliance, Handok Pharmaceuticals sales and marketing update

BioAlliance granted Handok exclusive rights to market Loramyc miconazole in Korea, Taiwan, Singapore and Malaysia. BioAlliance will receive $1.5 million up front and is eligible for $1.5 million on t...